OWA
GILD icon

Opal Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Opal Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,066
Closed -$149K – 373
2026
Q1 		$149K Buy
+1,066
New +$149K 0.03% 238
2025
Q3 		– Sell
-1,372
Closed -$152K – 334
2025
Q2 		$152K Buy
1,372
+8
+0.6% +$851 0.04% 221
2025
Q1 		$153K Buy
+1,364
New +$141K 0.05% 211
2024
Q3 		– Sell
-1,196
Closed -$82.1K – 581
2024
Q2 		$82.1K Buy
+1,196
New +$79.8K 0.03% 302

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Opal Wealth Advisors's GILD Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,066 shares — an estimated $149K sold.

Opal Wealth Advisors first reported a position in GILD in Q2 2024 and held it in 4 quarters. The position peaked at $153K in Q1 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 1,066 Gilead Sciences shares in Q2 2026, an estimated $149K.
  • Opal Wealth Advisors first reported a position in Gilead Sciences in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's Gilead Sciences position peaked at $153K in Q1 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.